Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
86.92
0.00
(0.00%)
At close: February 28 at 8:05:57 AM GMT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 13 | 13 | 19 | 19 |
| Avg. Estimate | 4.94B | 4.99B | 20.1B | 20.93B |
| Low Estimate | 4.78B | 4.84B | 19.7B | 20.54B |
| High Estimate | 5.02B | 5.06B | 20.85B | 21.51B |
| Year Ago Sales | 5.07B | 5.06B | 20.1B | 20.1B |
| Sales Growth (year/est) | -2.43% | -1.39% | 0.02% | 4.10% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CPAD.XC | -- | -- | -- | -- |
| S&P 500 | 16.04% | 7.30% | 10.63% | 14.23% |
Upgrades & Downgrades
| Maintains | JP Morgan: Overweight to Overweight | 2/3/2025 |
| Maintains | UBS: Buy to Buy | 2/3/2025 |
| Maintains | Stifel: Hold to Hold | 2/3/2025 |
| Maintains | RBC Capital: Sector Perform to Sector Perform | 2/3/2025 |
| Reiterates | Raymond James: Outperform to Outperform | 2/3/2025 |
| Maintains | Morgan Stanley: Overweight to Overweight | 2/3/2025 |